NCT02873923View on ClinicalTrials.gov

Variability of Definitions for Survival Endpoints and Surrogate Properties for OS in Sarcoma Trials: a Meta-analysis

CompletedOBSERVATIONAL
Enrollment

2,846

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 1, 2017

Study Completion Date

January 1, 2017

Conditions
Cancer
Interventions
DRUG

undefined

Chemotherapy drug (meta-analyses of randomized trials)

Sponsors

Lead Sponsor

Institut Bergonié
All Listed Sponsors
collaborator

National Cancer Institute, France

OTHER_GOV

collaborator

Ligue contre le cancer, France

OTHER

collaborator

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

collaborator

Centre Georges Francois Leclerc

OTHER

lead

Institut Bergonié

OTHER

NCT02873923 - Variability of Definitions for Survival Endpoints and Surrogate Properties for OS in Sarcoma Trials: a Meta-analysis | Biotech Hunter | Biotech Hunter